Literature DB >> 1248654

Urinary kallikrein in hypertensive animal models.

H R Keiser, R G Geller, H S Margolius, J J Pisano.   

Abstract

Urinary kallikrein excretion was studied in a number of animal models of hypertension. Kallikrein excretion was subnormal in spontaneously hypertensive rats as compared to Wistar/Kyoto rats and in rats made hypertensive by a clip on one renal artery. Kallikrein excretion was supranormal in rats made hypertensive by desoxycorticosterone and salt and in rats receiving desoxycorticosterone alone. It was subnormal after bilateral adrenalectomy. Kallikrein excretion increased in normotensive rats fed a low-sodium diet but was unchanged by a high-sodium diet. Thus, kallikrein excretion responded to changes in activity of sodium-retaining steroids and was not correlated with excretion of salt or water. In studies in dogs with stenosis of one renal artery kallikrein excretion was decreased on the stenoic side and the decrease correlated highly with the reduction in renal blood flow. While the role of the kallikrein-kinin system is still unclear the data indicate that the kidney may modify the initiation or maintenance of hypertension via this potent vasodilator system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1248654

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  13 in total

1.  Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.

Authors:  S B Levy; J J Lilley; R P Frigon; R A Stone
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

2.  A simple high-yield procedure for isolation of human urinary kallikreins.

Authors:  N B Oza; J W Ryan
Journal:  Biochem J       Date:  1978-04-01       Impact factor: 3.857

3.  Kinin-forming system in the genesis of hypertension.

Authors:  J N Sharma
Journal:  Agents Actions       Date:  1984-02

4.  Increased kallikrein excretion in spontaneously hypertensive rats and its inhibition by 6-hydroxydopamine.

Authors:  W Rascher; G Bönner; M Stocker; F Gross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

5.  Renal kallikrein in diabetic patients with hypertension accompanied by nephropathy.

Authors:  T Baba; S Murabayashi; T Ishizaki; Y Ido; K Aoyagi; K Takebe
Journal:  Diabetologia       Date:  1986-03       Impact factor: 10.122

6.  Effect of metoprolol on 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension.

Authors:  E Fritschka; R Gotzen; R Kittler; M Schöneshöfer
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

7.  Chronic kinin receptor blockade induces hypertension in deoxycorticosterone-treated rats.

Authors:  P Madeddu; V Anania; P P Parpaglia; M P Demontis; M V Varoni; M C Fattaccio; N Glorioso
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

8.  Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist.

Authors:  J R Cockcroft; P J Chowienczyk; S E Brett; N Bender; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

Review 9.  The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Authors:  Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

10.  Distribution of glomerular peripolar cells in different mammalian species.

Authors:  J A Gall; D Alcorn; A Butkus; J P Coghlan; G B Ryan
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.